References
- Walker Z, Jaros E, Walker RW et al. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J. Neurol. Neurosurg. Psychiatr. 78(11), 1176–1181 (2007).
- Eerola J, Tienari PJ, Kaakkola S, Nikkinen P, Launes J. How useful is [123I]b-CIT SPECT in clinical practice? J. Neurol. Neurosurg. Psychiatr. 76(9), 1211–1216 (2005).
- Ravina B, Eidelberg D, Ahlskog JE et al. The role of radiotracer imaging in Parkinson disease. Neurology 64(2), 208–215 (2005).
- Marshall VL, Reininger CB, Marquardt M et al. Parkinson’s disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT. Mov. Disord. 24(4), 500–508 (2009).
- de la Fuente-Fernández R. Role of DaTSCAN and clinical diagnosis in Parkinson disease. Neurology 78, 696–701 (2012).
- Jeon BS, Jeong JM, Park SS et al. Dopamine transporter density measured by [123I] b-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia. Ann. Neurol. 43(6), 792–800 (1998).
- Smith-Bindman R, Lipson J, Marcus R et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch. Intern. Med. 169(22), 2078–2086 (2009).
- Tolosa E, Borght TV, Moreno E; DaTSCAN Clinically Uncertain Parkinsonian Syndromes Study Group. Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study. Mov. Disord. 22(16), 2346–2351 (2007).
- Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125(Pt 4), 861–870 (2002).
- Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism – a prospective study. Can. J. Neurol. Sci. 18(3), 275–278 (1991).
- Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatr. 55(3), 181–184 (1992).
- Ansorge O, Lees AJ, Daniel SE. Up date on the accuracy of clinical diagnosis of idiopathic Parkinson’s disease [abstract]. Mov. Disord. 12(Suppl. 1), 96 (1997).
- Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease. Neurology 57(8), 1497–1499 (2001).
- Serrano Vicente J, García Bernardo L, Durán Barquero C et al. Negative predictive value of 123I Ioflupane SPECT in movement disorders. Rev. Esp. Med. Nucl. 28(1), 2–5 (2009).
- Benamer TS, Patterson J, Grosset DG et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov. Disord. 15(3), 503–510 (2000).
- Kupsch A, Bajaj H, Weiland F et al. Changes in clinical management following DaTscan (ioflupane) imaging in patients with a clinically uncertain parkinsonian syndrome: interim report. Poster session IV: poster discussion session. 63rd AAN Annual Meeting. Honolulu, HI, USA, 13 April 2011.
Websites
- European Medicines Agency. www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000266/human_med_000739.jsp&mid=WC0b01ac058001d125&murl=menus/medicines/medicines.jsp&jsenabled=true (Accessed 6 April 2012)
- Parkinson’s Disease Overview. National Parkinson Foundation. www.parkinson.org/parkinson-s-disease.aspx (Accessed 6 April 2012)
- US FDA. PCNS Advisory Committee Briefing Document. www.fda.gov/downloads/AdvisoryCommittees/…/UCM176192.pdf (Accessed 6 April 2012)
- AAN: Ioflupane SPECT imaging can diagnose Parkinson’s disease. www.molecularimaging.net/index.php?option=com_articles&view=article&id=27260:aan-ioflupane-spect-imaging-can-diagnose-parkinsons-disease (Accessed 6 April 2012)